Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Allograft rejection | R-HSA-9679028 | map05330 | Prestwick-864 | None | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | Prestwick-864 | None | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | Prestwick-864 | None | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-864 | None | drug-path |
Ribosome | R-HSA-5368277 | map03010 | Prestwick-864 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | roxithromycin | 5906 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | roxithromycin | 5906 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | roxithromycin | 5906 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | roxithromycin | 5906 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | roxithromycin | 5906 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | procyclidine | 4919 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | procyclidine | 4919 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | procyclidine | 4919 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | procyclidine | 4919 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | benzthiazide | 456255 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | benzthiazide | 456255 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | benzthiazide | 456255 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | benzthiazide | 456255 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | benzthiazide | 456255 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzthiazide | 456255 | drug-path |